TY  - GEN
AU  - Lemoine,Maud
AU  - Shimakawa,Yusuke
AU  - Njie,Ramou
AU  - Taal,Makie
AU  - Ndow,Gibril
AU  - Chemin,Isabelle
AU  - Ghosh,Sumantra
AU  - Njai,Harr F
AU  - Jeng,Adam
AU  - Sow,Amina
AU  - Toure-Kane,Coumba
AU  - Mboup,Souleymane
AU  - Suso,Penda
AU  - Tamba,Saydiba
AU  - Jatta,Abdullah
AU  - Sarr,Louise
AU  - Kambi,Aboubacar
AU  - Stanger,William
AU  - Nayagam,Shevanthi
AU  - Howell,Jessica
AU  - Mpabanzi,Liliane
AU  - Nyan,Ousman
AU  - Corrah,Tumani
AU  - Whittle,Hilton
AU  - Taylor-Robinson,Simon D
AU  - D'Alessandro,Umberto
AU  - Mendy,Maimuna
AU  - Thursz,Mark R
TI  - Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study
SN  - 2214-109X
PY  - 2018///0123
KW  - Adult
KW  - Age Factors
KW  - Antiviral Agents
KW  - Blood Donors
KW  - Communicable Diseases
KW  - Feasibility Studies
KW  - Female
KW  - Gambia
KW  - epidemiology
KW  - Hepatitis B
KW  - diagnosis
KW  - Hepatitis B Surface Antigens
KW  - blood
KW  - Hepatitis B virus
KW  - immunology
KW  - Humans
KW  - Liver Cirrhosis
KW  - Male
KW  - Mass Screening
KW  - methods
KW  - Middle Aged
KW  - Point-of-Care Systems
KW  - Prevalence
KW  - Sex Factors
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/S2214-109X(16)30130-9
ER  -